Shohani Hormonal Guard (SHG): A Multifunctional Nutraceutical Approach to Treating Polycystic Ovary Syndrome Through Metabolic, Hormonal, and Anti-Inflammatory Pathways

Polycystic Ovary Syndrome (PCOS) is a complex endocrine-metabolic disorder affecting women of reproductive age. It is characterized by ovarian dysfunction, insulin resistance, and hyperandrogenism, often accompanied by an overactive hypothalamic-pituitary-adrenal (HPA) axis. “Shohani Hormonal Guard” (SHG) is a nutraceutical formulation designed to target PCOS pathophysiology via multiple ingredients. We present a comprehensive review of SHG’s components – including inositols, N-acetylcysteine (NAC), berberine, ashwagandha, omega-3 fatty acids, and micronutrients (zinc, magnesium, vitamin B6, vitamin D3/K2, resveratrol, chromium, probiotics, etc.) – and their mechanistic roles and clinical benefits in PCOS. The literature demonstrates that SHG’s ingredients improve insulin sensitivity, modulate cortisol and adrenal function, restore hormonal balance, and reduce inflammation and oxidative stress. We discuss how these agents synergistically address PCOS’s root disturbances, potentially enhancing ovulatory function, metabolic health, and quality of life. This evidence-based analysis highlights SHG as a multi-targeted adjunct for PCOS management, aligning with current clinical and nutritional recommendations.